Sell Dr Reddys Laboratories: Sukhani

Published on Wed, Feb 15, 2012 at 08:57 |  Source : CNBC-TV18

Updated at Wed, Feb 15, 2012 at 10:35  

19715 Investors following Dr Reddys Labs. Share this News with them.
0
0
Share on Tumblr
Sudarshan Sukhani , s2analytics.com

Excerpts from Bazaar on CNBC-TV18 Watch the full show ยป

ALSO READ

Sudarshan Sukhani of s2analytics.com is of the view that one can sell Dr Reddys Laboratories .

Sukhani told CNBC-TV18, "Dr Reddys Laboratories is clearly making a distribution at higher levels at Rs 1,670-1,690. It's been trading in that range and then it has broken down from that range. So there is a very clear message that Dr Reddy's is going through a correction now."

He further added, "There is probably money on the downside even if the broad market goes up. This happens quite often. We see how pharma outperforms when markets are down and how it suddenly turns an underperformer when the high-beta stocks start catching up. I think that's normal cyclical and that's what happening here. But probably we can even see a much lower levels of Rs 1,550 or Rs 1,600. So, Dr Reddys not just for today is a sell buy also for the next few days."

  

Trending News

Business News

Panasonic Lumix SZ1
Morgan Stanley bomb: Predicts India's 2012 GDP at 5.7% "Morgan Stanley bomb: Predicts India's 2012 GDP at 5.7%"

Truce in BJP? Modi meets Advani, Vajpayee

Re-listing Guidelines Lock-in On Promoter Grp Hold For 1 Yr Fm Date Of Re-listing

The latest earning numbers FIRST on CNBC-TV18
Videos

Jun 1 2012, 19:15

Market may dip 10-15% this month: Jeff Chowdhry

- in FII View

Jun 1 2012, 11:57

Raamdeo Agrawal lauds Q4 nos, sees drastic rate cuts ahead

- in MARKET OUTLOOK

Interviews

Jun 1 2012, 15:36 | Source: CNBC-TV18

M&M performed well on strategy, not fuel prices: Nayer  

Jun 1 2012, 11:29 | Source: CNBC-TV18

HDIL eyes revenues of Rs 2500 cr in FY13  

Subscribe to

Moneycontrol Newsletters

Moneycontrol.com offers you a choice of various sectoral and other newsletters for FREE!